Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
RAPT Therapeutics, Inc.
RAPT Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Corvus Pharmaceuticals, Inc.
Rutgers, The State University of New Jersey
Eastern Cooperative Oncology Group
Ludwig Institute for Cancer Research
Celgene
University College, London
Institut Bergonié
Incyte Corporation
Peking University
INSYS Therapeutics Inc
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center